Scott Leatham, NP
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,353 of the $13,633 with a category attached, or 68.6%. It is spread thinly across 29 manufacturers, the largest accounting for just 13.9%. Reporting peaked in 2024 at $4,473 and has fallen 53.5% since, to $2,080 in 2025. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 527 payments — averaging $25.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$2K
- AbbVie$2K
- UCB, Inc.$2K
- Arcutis Biotherapeutics, Inc.$1K
- Lilly USA, LLC$770
- Galderma Laboratories, L.p.$717
- plus $5K from 23 others
What the payments were for
- Consulting fees$4,00329%
- Food & beverage$9,35369%
- Education$2772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $1,889 |
| AbbVie | 129 | $1,639 |
| UCB, Inc. | 20 | $1,625 |
| Arcutis Biotherapeutics, Inc. | 15 | $1,495 |
| Lilly USA, LLC | 38 | $770 |
| Galderma Laboratories, L.p. | 55 | $717 |
| Sun Pharmaceutical Industries Inc. | 30 | $681 |
| Johnson & Johnson | 36 | $675 |
| Pfizer | 34 | $544 |
| Incyte Corporation | 21 | $523 |
| Dermavant Sciences, Inc. | 20 | $411 |
| Sanofi | 10 | $336 |
| LEO Pharma Inc. | 15 | $330 |
| Biofrontera Inc. | 16 | $324 |
| E.r. Squibb & Sons, L.L.C. | 10 | $323 |
| Novartis | 20 | $267 |
| Organon | 13 | $236 |
| Regeneron Healthcare Solutions, Inc. | 10 | $220 |
| VYNE Pharmaceuticals Inc. | 4 | $189 |
| Amgen | 7 | $148 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Boehringer Ingelheim | 2 | $45 |
| Journey Medical Corporation | 2 | $40 |
| Genentech USA, Inc. | 2 | $33 |
| Biowound Solutions, Inc. | 1 | $29 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Almirall LLC | 1 | $18 |
| Botanix SB Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,633 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 19 | $675 |
| Imiquimod | 12 | $316 |
| Triamcinolone Acetonide | 28 | $303 |
| Ketoconazole | 14 | $273 |
| Minoxidil | 14 | $173 |
Paid to pharmacies, not to this prescriber.
Other family in Lehi
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$395K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
- Mary SteinbackSalt Lake City$189K
- Shannon FordSouth Jordan$186K
- Jennalyn MayeuxSalt Lake City$151K
- Brett RawlinsKaysville$149K
- Shelby MillerSandy$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.